Abstract Background Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide. but current treatment options remain limited and cause serious life-threatening side effects. Aberrant FGFR4 signaling has been validated as an oncogenic driver of HCC. and EZH2. https://sportsplazanyes.shop/product-category/n-a/